[
    {
        "molecule_name": "Bispecific CD3-CD19 scFv",
        "protein_target_name": "CD19",
        "binding_metric": "Kd",
        "value": "9.3 ± 0.6",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nThe K<sub>D </sub>for v873 and v875 binding to CD19 expressing Raji cells is similar across all antibodies and is comparable to v891.\nTABLE 1KD summary of T and B cell binding determined by FACSJurkatHBP-ALLRajiBindingBindingBinding(nM)(nM)(nM)v8739.3 ± 0.6 11.2 ± 1.0 2.7 ± 0.5v8754.5 ± 0.0034.7 ± 0.34.5 ± 0.9v891NA64.5 ± 70.32.7 ± 1.2\nTABLE 2Summary of binding properties of heteromultimers to Raji B cellsv875v1379v1380v1381v891Bmax13140109789955138924153Hill0.97891.0671.2301.2061.072slopeKD2.4912.1242.9462.3602.841\nTABLE 3Summary of binding properties of heteromultimers to HBP-ALL T cellsv875v1379v1380v1381OKT3v891Bmax17118279972042099557133396295Hill1.0991.1041.2960.91481.1950.8300slopeKD19.0517.897.547508.40.4607168.4"
    },
    {
        "molecule_name": "Bispecific T-cell engager (BiTE) antibody construct targeting CD3 and CD19",
        "protein_target_name": "CD19",
        "binding_metric": "Kd",
        "value": "4.5 ± 0.003",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nThe K<sub>D </sub>for v873 and v875 binding to CD19 expressing Raji cells is similar across all antibodies and is comparable to v891.\nTABLE 1KD summary of T and B cell binding determined by FACSJurkatHBP-ALLRajiBindingBindingBinding(nM)(nM)(nM)v8739.3 ± 0.6 11.2 ± 1.0 2.7 ± 0.5v8754.5 ± 0.0034.7 ± 0.34.5 ± 0.9v891NA64.5 ± 70.32.7 ± 1.2\nTABLE 2Summary of binding properties of heteromultimers to Raji B cellsv875v1379v1380v1381v891Bmax13140109789955138924153Hill0.97891.0671.2301.2061.072slopeKD2.4912.1242.9462.3602.841\nTABLE 3Summary of binding properties of heteromultimers to HBP-ALL T cellsv875v1379v1380v1381OKT3v891Bmax17118279972042099557133396295Hill1.0991.1041.2960.91481.1950.8300slopeKD19.0517.897.547508.40.4607168.4"
    },
    {
        "molecule_name": "Blinatumomab",
        "protein_target_name": "CD19",
        "binding_metric": "Kd",
        "value": "NA",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nThe K<sub>D </sub>for v873 and v875 binding to CD19 expressing Raji cells is similar across all antibodies and is comparable to v891.\nTABLE 1KD summary of T and B cell binding determined by FACSJurkatHBP-ALLRajiBindingBindingBinding(nM)(nM)(nM)v8739.3 ± 0.6 11.2 ± 1.0 2.7 ± 0.5v8754.5 ± 0.0034.7 ± 0.34.5 ± 0.9v891NA64.5 ± 70.32.7 ± 1.2\nTABLE 2Summary of binding properties of heteromultimers to Raji B cellsv875v1379v1380v1381v891Bmax13140109789955138924153Hill0.97891.0671.2301.2061.072slopeKD2.4912.1242.9462.3602.841\nTABLE 3Summary of binding properties of heteromultimers to HBP-ALL T cellsv875v1379v1380v1381OKT3v891Bmax17118279972042099557133396295Hill1.0991.1041.2960.91481.1950.8300slopeKD19.0517.897.547508.40.4607168.4"
    }
]